These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

718 related articles for article (PubMed ID: 33934077)

  • 1. Safety of the Methotrexate-leflunomide Combination in Rheumatoid Arthritis: Results of a Multicentric, Registry-based, Cohort Study (BiobadaBrasil).
    Bredemeier M; Ranza R; Kakehasi AM; Ranzolin A; da Silveira IG; Ribeiro ACM; Titton DC; Hayata ALS; Carvalho HMS; Kahlow BS; Fernandes V; Louzada P; Bértolo MB; Duarte ÂLBP; Macieira JC; Miranda JRS; Pinheiro GRC; Teodoro RB; Pinheiro MM; Valim V; Pereira IA; Sauma MFLC; de Castro GRW; da Rocha LF; Studart SAS; Gazzeta MO; da Silveira LG; Lupo CM; Laurindo IMM
    J Rheumatol; 2021 Oct; 48(10):1519-1527. PubMed ID: 33934077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide.
    Curtis JR; Beukelman T; Onofrei A; Cassell S; Greenberg JD; Kavanaugh A; Reed G; Strand V; Kremer JM
    Ann Rheum Dis; 2010 Jan; 69(1):43-7. PubMed ID: 19147616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival and effectiveness of leflunomide compared with methotrexate and sulfasalazine in rheumatoid arthritis: a matched observational study.
    Aletaha D; Stamm T; Kapral T; Eberl G; Grisar J; Machold KP; Smolen JS
    Ann Rheum Dis; 2003 Oct; 62(10):944-51. PubMed ID: 12972472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse events with disease modifying antirheumatic drugs (DMARD): a cohort study of leflunomide compared with other DMARD.
    Cannon GW; Holden WL; Juhaeri J; Dai W; Scarazzini L; Stang P
    J Rheumatol; 2004 Oct; 31(10):1906-11. PubMed ID: 15468352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group.
    Sharp JT; Strand V; Leung H; Hurley F; Loew-Friedrich I
    Arthritis Rheum; 2000 Mar; 43(3):495-505. PubMed ID: 10728741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
    Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The SMILE study -- safety of methotrexate in combination with leflunomide in rheumatoid arthritis.
    Bird P; Griffiths H; Tymms K; Nicholls D; Roberts L; Arnold M; Burnet S; de Jager J; Scott J; Zochling J; Littlejohn G
    J Rheumatol; 2013 Mar; 40(3):228-35. PubMed ID: 23322457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological and targeted-synthetic disease-modifying anti-rheumatic drugs with concomitant methotrexate or leflunomide in rheumatoid arthritis: real-life TReasure prospective data.
    Kimyon G; Kalyoncu U; Kiraz S; Bes C; Coşkun N; Yağiz B; Küçükşahin O; Kanitez N; Erden A; Kiliç L; Bilgin E; Kaşifoğlu T; Emmungil H; Koca SS; Akar S; Çinar M; Yazisiz V; Ateş A; Ersözlü D; Gönüllü E; Mercan R; Ertenli İ
    Clin Exp Rheumatol; 2021; 39(4):852-858. PubMed ID: 32896266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effectiveness of tocilizumab with either methotrexate or leflunomide in the treatment of rheumatoid arthritis.
    Narváez J; Díaz-Torné C; Magallares B; Hernández MV; Reina D; Corominas H; Sanmartí R; de la Serna AR; Llobet JM; Nolla JM
    PLoS One; 2015; 10(4):e0123392. PubMed ID: 25830224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver toxicity is rare in rheumatoid arthritis patients using combination therapy with leflunomide and methotrexate.
    Alves JA; Fialho SC; Morato EF; Castro GR; Zimmermann AF; Ribeiro GG; Neves FS; Pereira IA
    Rev Bras Reumatol; 2011; 51(2):141-4. PubMed ID: 21584420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Step-up combination versus switching of non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a retrospective observational study.
    Schoels M; Kapral T; Stamm T; Smolen JS; Aletaha D
    Ann Rheum Dis; 2007 Aug; 66(8):1059-65. PubMed ID: 17307765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of concomitant use of DMARDs on the persistence with anti-TNF therapies in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Soliman MM; Ashcroft DM; Watson KD; Lunt M; Symmons DP; Hyrich KL;
    Ann Rheum Dis; 2011 Apr; 70(4):583-9. PubMed ID: 21330639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness of rituximab in combination with either methotrexate or leflunomide in the treatment of rheumatoid arthritis.
    Narváez J; Díaz-Torné C; Ruiz JM; Hernández MV; Torrente-Segarra V; Ros S; Rodriguez de la Serna A; Díaz-López C; Sanmartí R; Nolla JM
    Semin Arthritis Rheum; 2011 Dec; 41(3):401-5. PubMed ID: 21862107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of Tumor Necrosis Factor Inhibitors in Combination with Various csDMARD in the Treatment of Rheumatoid Arthritis: Data from the DREAM Registry.
    Manders SH; Kievit W; Jansen TL; Stolk JN; Visser H; Schilder AM; Vonkeman HE; Adang E; van de Laar MA; van Riel PL
    J Rheumatol; 2016 Oct; 43(10):1787-1794. PubMed ID: 27481900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of antimalarials on the safety and persistence of treatment with biologic agents or Janus kinase inhibitors in rheumatoid arthritis.
    Bredemeier M; Duarte ÂL; Pinheiro MM; Kahlow BS; Macieira JC; Ranza R; Miranda JR; Valim V; de Castro GR; Bértolo MB; Sauma MF; Fernandes V; Ribeiro AC; Teodoro RB; Brenol CV; Carvalho HM; Studart SA; Pinheiro GR; da Rocha LF; de Lima HD; Pereira IA; Gazzeta MO; Kakehasi AM; Louzada P; Hayata AL; Lupo CM; da Silveira IG; Kowalski SC; Titton DC; Chakr RM; Ranzolin A; Xavier RM; Laurindo IM
    Rheumatology (Oxford); 2024 Feb; 63(2):456-465. PubMed ID: 37216912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of combination therapies in the treatment of rheumatoid arthritis: leflunomide-anti-TNF-alpha versus methotrexate-anti-TNF-alpha.
    De Stefano R; Frati E; Nargi F; Baldi C; Menza L; Hammoud M; Galeazzi M
    Clin Rheumatol; 2010 May; 29(5):517-24. PubMed ID: 20082236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of combination therapy with methotrexate and sinomenine or leflunomide for active rheumatoid arthritis: A randomized controlled clinical trial.
    Huang RY; Pan HD; Wu JQ; Zhou H; Li ZG; Qiu P; Zhou YY; Chen XM; Xie ZX; Xiao Y; Huang QC; Liu L
    Phytomedicine; 2019 Apr; 57():403-410. PubMed ID: 30851515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: open-label extension of a randomized, double-blind, placebo controlled trial.
    Kremer J; Genovese M; Cannon GW; Caldwell J; Cush J; Furst DE; Luggen M; Keystone E; Bathon J; Kavanaugh A; Ruderman E; Coleman P; Curtis D; Kopp E; Kantor S; Weisman M; Waltuck J; Lindsley HB; Markenson J; Crawford B; Fernando I; Simpson K; Strand V
    J Rheumatol; 2004 Aug; 31(8):1521-31. PubMed ID: 15290730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: a population-based study.
    Finckh A; Dehler S; Gabay C;
    Ann Rheum Dis; 2009 Jan; 68(1):33-9. PubMed ID: 18230627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retention of triple therapy with methotrexate, sulfasalazine, and hydroxychloroquine compared to combination methotrexate and leflunomide in rheumatoid arthritis.
    Bhavsar SV; Movahedi M; Cesta A; Pope JE; Bombardier C;
    Joint Bone Spine; 2024 Jul; 91(4):105732. PubMed ID: 38583692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.